Night-Time Apomorphine Infusion: Who Are the Best Candidates?
Mov Disord Clin Pract
; 10(8): 1192-1197, 2023 Aug.
Article
em En
| MEDLINE
| ID: mdl-37635769
ABSTRACT
Background:
We recently demonstrated in a randomized controlled trial (APOMORPHEE, NCT02940912) that night-time only subcutaneous apomorphine infusion improves sleep disturbances and insomnia in patients with advanced Parkinson's disease and moderate to severe insomnia.Objectives:
To identify the best candidates for receiving night-time only subcutaneous apomorphine infusion in routine care.Methods:
In this post-hoc analysis of APOMORPHEE, we compared the characteristics of patients according to whether they chose to continue night-time only subcutaneous apomorphine infusion at the end of the study period or not.Results:
Half of the patients (22/42) chose to continue the treatment. Off duration (day or night), painful Off dystonia, and insomnia severity at baseline were associated with night-time only apomorphine continuation. Multivariate analysis retained only Off duration as an independent predictor of continuation.Conclusions:
The best candidates for night-time only apomorphine are patients with severe and prolonged Off periods (day or night) and severe insomnia.
Texto completo:
1
Base de dados:
MEDLINE
Tipo de estudo:
Clinical_trials
/
Prognostic_studies
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article